Clinical trials find one-time gene therapy exa-cel offers ‘functional cure’ in 96.6% of patients
A “groundbreaking” £1.65m treatment offering a potential cure for people in England living with sickle cell disease has been approved for use on the NHS, the medicines watchdog has announced.
Campaigners welcomed news of the approval of the one-time gene therapy, known as exagamglogene autotemcel, or exa-cel, which edits the faulty gene in a patient’s own stem cells.
More Stories
From the Beatles to biologics – how Liverpool became a life science hotspot
Ancient British coins found in Dutch field likely to be spoils of Roman conquest
Citizen Sleeper 2: Starward Vector review – we’re putting together a crew